Acumen Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $57.2M | $239.0M | $35.6M |
| FY2025 | $52.4M | $122.8M | $54.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $57.2M | $239.0M | $35.6M |
| FY2025 | $52.4M | $122.8M | $54.0M |